India, June 9 -- Lung cancer remains Australia's leading cause of cancer death, with around 15,000 diagnoses annually.

Now, researchers have identified a distinct blood-based protein signature that could predict lung cancer risk years before diagnosis, offering new hope for earlier detection and prevention strategies against Australia's deadliest cancer. Published in the journal Cell, the landmark study suggests that this molecular signal could help identify high-risk individuals who may benefit from preventive treatment even before cancer develops. The research was conducted through a collaboration between the Francis Crick Institute and University College London (UCL), and co-led by WEHI laboratory head Dr Clare Weeden, who carried out...